Suppr超能文献

超声乳化白内障吸除术、前段玻璃体切除术和巩膜切除术联合治疗青光眼小眼球的疗效。

Outcomes of combined phacoemulsification, anterior vitrectomy, and sclerectomy in nanophthalmic eyes with glaucoma.

机构信息

Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.

NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.

出版信息

Eye (Lond). 2023 Mar;37(4):751-759. doi: 10.1038/s41433-022-02039-w. Epub 2022 Apr 5.

Abstract

OBJECTIVES

To compare the long-term efficacy and safety of combined phacoemulsification, anterior vitrectomy, and sclerectomy (triple procedure surgery, TS); combined phacoemulsification and anterior vitrectomy (double procedure surgery, DS); and filtering surgery (FS) in nanophthalmos with angle-closure glaucoma (NACG).

METHODS

Retrospective cohort study. Forty patients (44 eyes) diagnosed with NACG who underwent TS, DS, and FS were included. All eyes in the TS group and seven (47%) eyes in the DS group also underwent goniosynechialysis during the surgery. The main outcome measures (intraocular pressure [IOP], best-corrected visual acuity, complications, and second surgeries) were recorded at the early- (within 1 week) and late-stage (>3 months) follow-up.

RESULTS

The late-stage IOP was significantly lower in the TS (mean ± standard deviation: 13.29 ± 2.49 mm Hg) than in the DS (19.69 ± 6.97 mm Hg) and FS groups (27.57 ± 12.26 mm Hg, p < 0.001). More visual improvements were observed in the TS and DS groups than in the FS group at late-stage follow-up (p = 0.04). The complication rates in the TS, DS, and FS groups were 26%, 33%, and 70%, respectively (p = 0.046); the second surgery rates were 0%, 33%, and 60%, respectively (p < 0.001). In total, one, three, and six severe complications were observed in the TS, DS, and FS groups, respectively. The mean follow-up durations in the TS, DS, and FS groups were 18.89, 20.02, and 25.75 months, respectively.

CONCLUSIONS

NACG management remains challenging. TS presented relatively good clinical efficacy and safety with better postoperative IOP outcomes, lower complications, and second surgery rates among the three groups in eyes with NACG.

摘要

目的

比较白内障超声乳化吸除联合前段玻璃体切除联合巩膜切除术(三联手术,TS)、白内障超声乳化吸除联合前段玻璃体切除(二联手术,DS)和滤过性手术(FS)治疗闭角型青光眼伴小眼球(NACG)的长期疗效和安全性。

方法

回顾性队列研究。纳入 40 例(44 只眼)NACG 患者,分别接受 TS、DS 和 FS。TS 组所有眼和 DS 组 7 只眼(47%)术中同时行房角分离术。主要观察指标(眼压、最佳矫正视力、并发症和二次手术)在早期(术后 1 周内)和晚期(>3 个月)随访时记录。

结果

TS 组(平均±标准差:13.29±2.49mmHg)晚期眼压明显低于 DS 组(19.69±6.97mmHg)和 FS 组(27.57±12.26mmHg,p<0.001)。晚期随访时,TS 和 DS 组视力改善较 FS 组明显(p=0.04)。TS、DS 和 FS 组的并发症发生率分别为 26%、33%和 70%(p=0.046);二次手术率分别为 0%、33%和 60%(p<0.001)。TS、DS 和 FS 组分别有 1、3 和 6 例严重并发症。TS、DS 和 FS 组的平均随访时间分别为 18.89、20.02 和 25.75 个月。

结论

NACG 的治疗仍然具有挑战性。在 NACG 患者中,与 DS 和 FS 相比,TS 具有较好的临床疗效和安全性,术后眼压控制更好,并发症和二次手术率更低。

相似文献

1
Outcomes of combined phacoemulsification, anterior vitrectomy, and sclerectomy in nanophthalmic eyes with glaucoma.
Eye (Lond). 2023 Mar;37(4):751-759. doi: 10.1038/s41433-022-02039-w. Epub 2022 Apr 5.
2
Goniosynechialysis combined with multiple surgeries for secondary glaucoma in nanophthalmos: A case report.
Eur J Ophthalmol. 2022 Jan;32(1):NP71-NP75. doi: 10.1177/1120672120971187. Epub 2020 Nov 11.
3
Surgical management of malignant glaucoma with white cataract in nanophthalmos.
J Cataract Refract Surg. 2013 Nov;39(11):1774-7. doi: 10.1016/j.jcrs.2013.08.016. Epub 2013 Sep 7.
7
Clinical efficacy of modified partial pars plana vitrectomy combined with phacoemulsification for malignant glaucoma.
Eye (Lond). 2016 Aug;30(8):1094-100. doi: 10.1038/eye.2016.106. Epub 2016 May 27.

引用本文的文献

1
Sclerectomies in nanophthalmos and idiopathic uveal effusion syndrome: a systematic review.
Graefes Arch Clin Exp Ophthalmol. 2025 Jul 15. doi: 10.1007/s00417-025-06908-4.
2
Phacoemulsification combined glaucoma surgeries in the treatment of nanophthalmos patients with secondary angle closure glaucoma.
Graefes Arch Clin Exp Ophthalmol. 2025 Jun;263(6):1667-1674. doi: 10.1007/s00417-025-06770-4. Epub 2025 Feb 18.

本文引用的文献

1
Clinical spectrum and treatment outcomes of patients with nanophthalmos.
Eye (Lond). 2021 Mar;35(3):825-830. doi: 10.1038/s41433-020-0971-4. Epub 2020 May 28.
3
Nanophthalmos: A Review of the Clinical Spectrum and Genetics.
J Ophthalmol. 2018 May 9;2018:2735465. doi: 10.1155/2018/2735465. eCollection 2018.
4
The treatment of malignant glaucoma in nanophthalmos: a case report.
BMC Ophthalmol. 2018 Feb 23;18(1):54. doi: 10.1186/s12886-018-0714-5.
6
A Randomized Controlled Trial Comparing Outcomes of Cataract Surgery in Nanophthalmos With and Without Prophylactic Sclerostomy.
Am J Ophthalmol. 2017 Nov;183:125-133. doi: 10.1016/j.ajo.2017.09.008. Epub 2017 Sep 11.
7
Cataract surgery in patients with nanophthalmos: results and complications.
Eur J Ophthalmol. 2016 Mar-Apr;26(2):103-6. doi: 10.5301/ejo.5000656. Epub 2015 Aug 4.
8
Long-term clinical outcome and causes of vision loss in patients with uveitis.
Ophthalmology. 2014 Dec;121(12):2387-92. doi: 10.1016/j.ophtha.2014.07.007. Epub 2014 Aug 30.
9
Cataract surgery in small adult eyes.
Br J Ophthalmol. 2014 Sep;98(9):1261-5. doi: 10.1136/bjophthalmol-2013-304579. Epub 2014 Apr 23.
10
Outcomes of phacoemulsification and intraocular lens implantation in microphthalmos and nanophthalmos.
J Cataract Refract Surg. 2013 Jan;39(1):87-96. doi: 10.1016/j.jcrs.2012.08.057.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验